Apotex Pharmachem India 483, Jan 2014

Apotex Pharmachem India 483, Jan 2014

Peter Baker FDA, Dipesh Shah FDA$119.00

FDA investigators audited the Apotex Pharmachem India facility in Bangalore, India and issued inspectional observations (via FDA 483) on 31 Jan 2014.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 31 Jan 2014
  • Location: Bangalore, India